Transmitted HIV type 1 drug resistance and non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy

Chiara Riva, Alessia Lai, Ilaria Caramma, Stefano Corvasce, Michela Violin, Lorenzo Dehò, Francesca Prati, Cristina Rossi, Maria Chiara Colombo, Amedeo Capetti, Marco Franzetti, Valeria Rossini, Giuseppe Tambussi, Massimo Ciccozzi, Barbara Suligoi, Cristina Mussini, Giovanni Rezza, Claudia Balotta

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The patterns of transmitted drug-resistant (TDR) HIV-1 variants, non-B subtype spread, and epidemiological trends were evaluated either in seroconverters or in newly diagnosed individuals in Italy over a 13-year period. We analyzed 119 seroconverters, enrolled from 1992 to 2003 for the CASCADE study, and 271 newly diagnosed individuals of the SPREAD study (2002-2005), of whom 42 had a known seroconversion date. Overall, TDR was 15.1% in the CASCADE and 12.2% in the SPREAD study. In the 1992-2003 period, men having sex with men (MSMs) and heterosexuals (HEs) were 48.7% and 36.8%, respectively; TDR was found to be higher in MSMs compared to HEs (78.9% vs. 21%, p = 0.006). The same groups were 39.1% and 53.3% in the SPREAD study; however, no association was detected between modality of infection and TDR. Overall, 9.2% and 22.1% of individuals harbored a non-B clade virus in the CASCADE and SPREAD study, respectively. As evidence of onward transmission, 40% (24/60) of non-B variants were carried by European individuals in the latter study; among these patients the F1 subtype was highly prevalent (p = 0.00001). One of every eight patients who received a diagnosis of HIV-1 in recent years harbored a resistant variant, reinforcing the arguments for baseline resistance testing to customize first-line therapy in newly infected individuals. The spread of non-B clades may act as a dilution factor of TDR concealing the proportion of TDR in seroconverters and MSMs.

Original languageEnglish
Pages (from-to)41-49
Number of pages9
JournalAIDS Research and Human Retroviruses
Volume26
Issue number1
DOIs
Publication statusPublished - Jan 1 2010

Fingerprint

Drug Resistance
Italy
HIV-1
Pharmaceutical Preparations
Heterosexuality
Viruses
Infection

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Infectious Diseases

Cite this

Transmitted HIV type 1 drug resistance and non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy. / Riva, Chiara; Lai, Alessia; Caramma, Ilaria; Corvasce, Stefano; Violin, Michela; Dehò, Lorenzo; Prati, Francesca; Rossi, Cristina; Colombo, Maria Chiara; Capetti, Amedeo; Franzetti, Marco; Rossini, Valeria; Tambussi, Giuseppe; Ciccozzi, Massimo; Suligoi, Barbara; Mussini, Cristina; Rezza, Giovanni; Balotta, Claudia.

In: AIDS Research and Human Retroviruses, Vol. 26, No. 1, 01.01.2010, p. 41-49.

Research output: Contribution to journalArticle

Riva, C, Lai, A, Caramma, I, Corvasce, S, Violin, M, Dehò, L, Prati, F, Rossi, C, Colombo, MC, Capetti, A, Franzetti, M, Rossini, V, Tambussi, G, Ciccozzi, M, Suligoi, B, Mussini, C, Rezza, G & Balotta, C 2010, 'Transmitted HIV type 1 drug resistance and non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy', AIDS Research and Human Retroviruses, vol. 26, no. 1, pp. 41-49. https://doi.org/10.1089/aid.2009.0057
Riva, Chiara ; Lai, Alessia ; Caramma, Ilaria ; Corvasce, Stefano ; Violin, Michela ; Dehò, Lorenzo ; Prati, Francesca ; Rossi, Cristina ; Colombo, Maria Chiara ; Capetti, Amedeo ; Franzetti, Marco ; Rossini, Valeria ; Tambussi, Giuseppe ; Ciccozzi, Massimo ; Suligoi, Barbara ; Mussini, Cristina ; Rezza, Giovanni ; Balotta, Claudia. / Transmitted HIV type 1 drug resistance and non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy. In: AIDS Research and Human Retroviruses. 2010 ; Vol. 26, No. 1. pp. 41-49.
@article{42f4e406a3db47fdbcc7738488102c34,
title = "Transmitted HIV type 1 drug resistance and non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy",
abstract = "The patterns of transmitted drug-resistant (TDR) HIV-1 variants, non-B subtype spread, and epidemiological trends were evaluated either in seroconverters or in newly diagnosed individuals in Italy over a 13-year period. We analyzed 119 seroconverters, enrolled from 1992 to 2003 for the CASCADE study, and 271 newly diagnosed individuals of the SPREAD study (2002-2005), of whom 42 had a known seroconversion date. Overall, TDR was 15.1{\%} in the CASCADE and 12.2{\%} in the SPREAD study. In the 1992-2003 period, men having sex with men (MSMs) and heterosexuals (HEs) were 48.7{\%} and 36.8{\%}, respectively; TDR was found to be higher in MSMs compared to HEs (78.9{\%} vs. 21{\%}, p = 0.006). The same groups were 39.1{\%} and 53.3{\%} in the SPREAD study; however, no association was detected between modality of infection and TDR. Overall, 9.2{\%} and 22.1{\%} of individuals harbored a non-B clade virus in the CASCADE and SPREAD study, respectively. As evidence of onward transmission, 40{\%} (24/60) of non-B variants were carried by European individuals in the latter study; among these patients the F1 subtype was highly prevalent (p = 0.00001). One of every eight patients who received a diagnosis of HIV-1 in recent years harbored a resistant variant, reinforcing the arguments for baseline resistance testing to customize first-line therapy in newly infected individuals. The spread of non-B clades may act as a dilution factor of TDR concealing the proportion of TDR in seroconverters and MSMs.",
author = "Chiara Riva and Alessia Lai and Ilaria Caramma and Stefano Corvasce and Michela Violin and Lorenzo Deh{\`o} and Francesca Prati and Cristina Rossi and Colombo, {Maria Chiara} and Amedeo Capetti and Marco Franzetti and Valeria Rossini and Giuseppe Tambussi and Massimo Ciccozzi and Barbara Suligoi and Cristina Mussini and Giovanni Rezza and Claudia Balotta",
year = "2010",
month = "1",
day = "1",
doi = "10.1089/aid.2009.0057",
language = "English",
volume = "26",
pages = "41--49",
journal = "AIDS Research and Human Retroviruses",
issn = "0889-2229",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Transmitted HIV type 1 drug resistance and non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy

AU - Riva, Chiara

AU - Lai, Alessia

AU - Caramma, Ilaria

AU - Corvasce, Stefano

AU - Violin, Michela

AU - Dehò, Lorenzo

AU - Prati, Francesca

AU - Rossi, Cristina

AU - Colombo, Maria Chiara

AU - Capetti, Amedeo

AU - Franzetti, Marco

AU - Rossini, Valeria

AU - Tambussi, Giuseppe

AU - Ciccozzi, Massimo

AU - Suligoi, Barbara

AU - Mussini, Cristina

AU - Rezza, Giovanni

AU - Balotta, Claudia

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The patterns of transmitted drug-resistant (TDR) HIV-1 variants, non-B subtype spread, and epidemiological trends were evaluated either in seroconverters or in newly diagnosed individuals in Italy over a 13-year period. We analyzed 119 seroconverters, enrolled from 1992 to 2003 for the CASCADE study, and 271 newly diagnosed individuals of the SPREAD study (2002-2005), of whom 42 had a known seroconversion date. Overall, TDR was 15.1% in the CASCADE and 12.2% in the SPREAD study. In the 1992-2003 period, men having sex with men (MSMs) and heterosexuals (HEs) were 48.7% and 36.8%, respectively; TDR was found to be higher in MSMs compared to HEs (78.9% vs. 21%, p = 0.006). The same groups were 39.1% and 53.3% in the SPREAD study; however, no association was detected between modality of infection and TDR. Overall, 9.2% and 22.1% of individuals harbored a non-B clade virus in the CASCADE and SPREAD study, respectively. As evidence of onward transmission, 40% (24/60) of non-B variants were carried by European individuals in the latter study; among these patients the F1 subtype was highly prevalent (p = 0.00001). One of every eight patients who received a diagnosis of HIV-1 in recent years harbored a resistant variant, reinforcing the arguments for baseline resistance testing to customize first-line therapy in newly infected individuals. The spread of non-B clades may act as a dilution factor of TDR concealing the proportion of TDR in seroconverters and MSMs.

AB - The patterns of transmitted drug-resistant (TDR) HIV-1 variants, non-B subtype spread, and epidemiological trends were evaluated either in seroconverters or in newly diagnosed individuals in Italy over a 13-year period. We analyzed 119 seroconverters, enrolled from 1992 to 2003 for the CASCADE study, and 271 newly diagnosed individuals of the SPREAD study (2002-2005), of whom 42 had a known seroconversion date. Overall, TDR was 15.1% in the CASCADE and 12.2% in the SPREAD study. In the 1992-2003 period, men having sex with men (MSMs) and heterosexuals (HEs) were 48.7% and 36.8%, respectively; TDR was found to be higher in MSMs compared to HEs (78.9% vs. 21%, p = 0.006). The same groups were 39.1% and 53.3% in the SPREAD study; however, no association was detected between modality of infection and TDR. Overall, 9.2% and 22.1% of individuals harbored a non-B clade virus in the CASCADE and SPREAD study, respectively. As evidence of onward transmission, 40% (24/60) of non-B variants were carried by European individuals in the latter study; among these patients the F1 subtype was highly prevalent (p = 0.00001). One of every eight patients who received a diagnosis of HIV-1 in recent years harbored a resistant variant, reinforcing the arguments for baseline resistance testing to customize first-line therapy in newly infected individuals. The spread of non-B clades may act as a dilution factor of TDR concealing the proportion of TDR in seroconverters and MSMs.

UR - http://www.scopus.com/inward/record.url?scp=76449092247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449092247&partnerID=8YFLogxK

U2 - 10.1089/aid.2009.0057

DO - 10.1089/aid.2009.0057

M3 - Article

C2 - 20055587

AN - SCOPUS:76449092247

VL - 26

SP - 41

EP - 49

JO - AIDS Research and Human Retroviruses

JF - AIDS Research and Human Retroviruses

SN - 0889-2229

IS - 1

ER -